CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 64 enrolled
Drug / intervention
Masimo INVSENSOR00061device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05896267
NCT05896267N/ACompleted

SpO2 Data Collection in Pediatric Patients Using INVSENSOR00061

Masimo Corporation·interventional·Posted Jun 9, 2023·Updated Nov 12, 2025

In Brief

A clinical study evaluating Masimo INVSENSOR00061 for Spo2. Completed, enrolled 64 participants across 1 site.

Detailed Summary

This is a prospective, non-randomized data collection study to evaluate the form, fit, and function of INVSENSOR00061.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpo2
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedJun 9, 2023
Enrollment StartMay 15, 2023
Primary CompletionJun 22, 2023
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 3.1 years ago

Interventions

Masimo INVSENSOR00061device

Masimo INVSENSOR00061 will be used to measure noninvasive SpO2 (Oxygen Saturation )